Informe de análisis de tamaño, participación y tendencias del mercado global de gestión inteligente de la diabetes: descripción general de la industria y pronóstico hasta 2031

Análisis del mercado de gestión inteligente de la diabetes

El mercado de la gestión inteligente de la diabetes está evolucionando rápidamente, impulsado por los avances tecnológicos y un énfasis creciente en la atención médica personalizada. Este mercado abarca una variedad de dispositivos, incluidos medidores de glucosa inteligentes, sistemas de monitoreo continuo de glucosa y soluciones de administración de insulina que mejoran el control de la diabetes. Con el aumento de la prevalencia de la diabetes a nivel mundial, la demanda de soluciones innovadoras que faciliten el monitoreo en tiempo real y el análisis de datos está en aumento. Los desarrollos recientes, como las colaboraciones entre las principales empresas y el lanzamiento de nuevos productos como los monitores de glucosa integrados en los teléfonos inteligentes, están mejorando la experiencia y la accesibilidad del usuario. Además, la investigación y las asociaciones en curso tienen como objetivo mejorar la adherencia al tratamiento y los resultados del paciente a través de aplicaciones de salud digital. A medida que los sistemas de atención médica cambian hacia la atención preventiva y la autogestión, el mercado de la gestión inteligente de la diabetes está preparado para un crecimiento significativo, ofreciendo oportunidades prometedoras para las partes interesadas en el ecosistema de la atención médica.

Tamaño del mercado de gestión inteligente de la diabetes

El tamaño del mercado global de gestión inteligente de la diabetes se valoró en USD 7,44 mil millones en 2023 y se proyecta que alcance los USD 22,76 mil millones para 2031, con una CAGR del 15,00% durante el período de pronóstico de 2024 a 2031. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Tendencias del mercado de la gestión inteligente de la diabetes

“ Integración de la Inteligencia Artificial”

El mercado de la gestión inteligente de la diabetes está siendo testigo de tendencias transformadoras impulsadas por innovaciones tecnológicas que mejoran la atención al paciente. Una tendencia destacada es la integración de la inteligencia artificial (IA) y el aprendizaje automático en las herramientas de gestión de la diabetes. Estas tecnologías analizan grandes cantidades de datos de los monitores de glucosa y los dispositivos portátiles, lo que permite obtener información y recomendaciones personalizadas para los usuarios. Las innovaciones como las plumas de insulina inteligentes y los sistemas de circuito cerrado también están ganando terreno, lo que permite la administración automatizada de insulina en función de las lecturas de glucosa en tiempo real. Esta tendencia mejora la adherencia al tratamiento y permite a los pacientes tomar el control de su salud. Como resultado, el mercado está evolucionando para ofrecer soluciones más fáciles de usar y efectivas, lo que mejora significativamente los resultados del control de la diabetes.

Alcance del informe y segmentación del mercado de gestión inteligente de la diabetes         

Smart Diabetes Management Market Definition

Smart diabetes management is the use of advanced technology and digital tools to monitor and manage diabetes effectively, encompassing devices and applications that enable real-time tracking of blood glucose levels, personalized insights, and enhanced communication between patients and healthcare providers.

Smart Diabetes Management Market Dynamics

Drivers

• Rising Prevalence of Diabetes

The rising prevalence of diabetes worldwide is significantly driving the demand for effective management solutions. With an estimated 537 million adults living with diabetes as of 2021, this number is projected to rise sharply in the coming years due to factors such as sedentary lifestyles, poor dietary habits, and genetic predispositions. As a result, there is a pressing need for innovative tools and technologies that can help individuals monitor and manage their condition effectively. Smart diabetes management solutions, such as continuous glucose monitors and insulin delivery systems, provide real-time data and personalized insights, empowering patients to take control of their health. This urgent demand for efficient management options is propelling growth in the smart diabetes management market, making it a critical area for investment and development.

• Consumer Demand for Personalization

The shift towards personalized healthcare is significantly influencing the development of tailored diabetes management solutions. As patients increasingly seek customized care that aligns with their individual health needs and lifestyles, healthcare providers are responding by adopting technologies that offer personalized insights and recommendations. Innovations such as smart glucose meters and mobile health applications allow for individualized monitoring and treatment adjustments based on real-time data. This trend enhances patient engagement and adherence and improves health outcomes by providing targeted interventions. Consequently, the demand for personalized diabetes management tools is driving growth in the smart diabetes management market.

Opportunities

• Integration of Wearable Technology

The proliferation of wearable devices presents significant opportunities for seamless integration with diabetes management solutions, fundamentally transforming how individuals monitor and manage their condition. These devices, including smartwatches and fitness trackers, can continuously collect vital health data such as blood glucose levels, physical activity, and heart rate. By integrating this data with diabetes management apps, users receive real-time feedback and personalized insights, empowering them to make informed decisions about their health. This continuous monitoring capability enhances patient engagement and facilitates proactive management, reducing the risk of complications. As consumer demand for wearable technology grows, the smart diabetes management market can leverage this trend to develop innovative solutions that improve patient outcomes and enhance the overall management experience.

• Advancement in Telehealth Services

The increasing acceptance of telehealth services is creating substantial opportunities for enhancing diabetes management through remote monitoring and consultations. This shift allows healthcare providers to connect with patients virtually, offering them the convenience of managing their condition from the comfort of their homes. For individuals living in remote or underserved areas, telehealth can significantly improve access to specialized care and diabetes management resources. Patients can benefit from real-time data sharing with healthcare professionals, enabling timely interventions and personalized care plans. Additionally, telehealth services often include educational resources and support systems that empower patients to take charge of their health. As telehealth continues to gain traction, the smart diabetes management market stands to capitalize on this trend by integrating remote monitoring solutions that improve patient outcomes and overall healthcare efficiency.

Restraints/Challenges

• High Costs of Investment

The high initial investment associated with advanced diabetes management technologies poses a significant challenge to widespread adoption among patients and healthcare providers. Many of these innovative solutions, such as continuous glucose monitoring systems and smart insulin pumps, come with substantial upfront costs that can deter potential users. For patients, especially those without adequate insurance coverage, the financial burden may limit access to essential management tools, impacting their ability to effectively control their condition. Healthcare providers, particularly smaller clinics and practices, may also find it difficult to allocate budget for these technologies, leading to disparities in care. Consequently, the prohibitive costs associated with adopting advanced diabetes management solutions can hinder their integration into everyday healthcare practices, ultimately affecting patient outcomes and overall market growth.

•  Limited Market Awareness

A significant lack of awareness regarding the benefits and functionalities of smart diabetes management technologies can impede their adoption among potential users. Many patients and healthcare providers may not fully understand how these innovative tools—such as continuous glucose monitors and mobile health applications—can enhance diabetes management and improve health outcomes. This gap in knowledge can lead to misconceptions or hesitance in adopting these technologies, as individuals may prefer traditional methods they are more familiar with. Additionally, without adequate education and outreach efforts from healthcare providers and manufacturers, patients may miss out on valuable opportunities for improved disease management. As a result, this lack of awareness can limit the overall growth and effectiveness of smart diabetes management solutions in the market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Smart Diabetes Management Market Scope

The market is segmented on the basis of devices, device type, application, diabetes type, and end use. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Devices

• Smart Glucose Meters
• Continuous Glucose Monitoring Systems
• Smart Insulin Pens
• Smart Insulin Pumps
• Closed Loop Systems

Device Type

• Handheld Devices
• Wearable Devices

Application

• Diabetes and Blood Glucose Tracking Apps
• Obesity and Diet Management Apps

Diabetes Type

• Type 1 Diabetes
• Type 2 Diabetes

End Use

• Home Healthcare
• Hospitals
• Specialty Diabetes Clinics

 Smart Diabetes Management Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, devices, device type, application, diabetes type, and end use as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the smart diabetes management market, primarily driven by the high prevalence of diabetes among its population. The region's favorable reimbursement policies further enhance access to advanced diabetes management technologies, making them more attainable for patients. Additionally, increased awareness and adoption of innovative solutions contribute to the robust growth of this market segment in North America.

The Asia-Pacific region is anticipated to experience the highest growth rate from 2024 to 2031, driven by the strategic focus of numerous established market players looking to expand their footprint in this dynamic market. This growing interest is fueled by the increasing prevalence of diabetes and the demand for advanced management solutions in the region. As companies invest in localized initiatives and innovative technologies, the Asia-Pacific market is poised for significant development and increased adoption of smart diabetes management solutions.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Smart Diabetes Management Market Share

El panorama competitivo del mercado proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y variedad de productos, y el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado.

Los líderes del mercado de gestión inteligente de la diabetes que operan en el mercado son:

• Abbott (Estados Unidos)
• PHC Holdings Corporation (Japón)
• Welldoc, Inc. (Estados Unidos)
• Sanofi (Francia)
• Dexcom, Inc. (Estados Unidos)
• DarioHealth Corp. (Estados Unidos)
• Medtronic (Irlanda)
• B. Braun SE (Alemania)
• F. Hoffmann-La Roche Ltd (Suiza)
• Corporación Insulet (Estados Unidos)
• Ascensia Diabetes Care Holdings AG (Suiza)
• Tandem Diabetes Care, Inc. (Estados Unidos)
• LifeScan IP Holdings, LLC (Estados Unidos)
• AgaMatrix (Estados Unidos)
• Glooko Inc. (Estados Unidos)

Últimos avances en el mercado de la gestión inteligente de la diabetes

• En abril de 2023, Glooko, Inc., una empresa de software líder, firmó una asociación global con Hedia, un desarrollador de algoritmos de dosificación de insulina. Esta colaboración tiene como objetivo crear una solución interoperable que combine la monitorización remota de pacientes, la atención conectada y las tecnologías terapéuticas digitales. De este modo, buscan mejorar el acceso para las personas con diabetes tipo 1 y tipo 2 que necesitan orientación sobre la dosificación de insulina en bolo.
• En mayo de 2023, Medtronic plc, una empresa líder mundial en tecnología sanitaria, anunció acuerdos definitivos para adquirir EOFlow Co. Ltd., conocida por sus innovadores parches de insulina portátiles. Esta adquisición tiene como objetivo mejorar las capacidades de administración automatizada de insulina y agilizar el tratamiento de la diabetes para los pacientes. Al incorporar la tecnología de EOFlow, Medtronic busca reforzar su posición en la industria y, al mismo tiempo, ampliar su oferta de productos para brindar un mejor servicio a las personas que controlan la diabetes.
• En octubre de 2021, Roche se asoció con Zur Rose Group para mejorar el apoyo a las personas con diabetes y a sus cuidadores en la gestión de los medicamentos diarios. Esta colaboración tiene como objetivo integrar las soluciones de Roche Diabetes Care con las de los principales proveedores externos, creando un ecosistema de atención médica más completo. Al conectar sus innovadores productos de atención médica, Roche y Zur Rose Group buscan mejorar la calidad de vida general de las personas que viven con diabetes.

SKU-52324